4/A//SEC Filing
Kolaja Carey OConnor 4/A
Accession 0001479290-22-000066
CIK 0001479290other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:10 PM ET
Size
5.9 KB
Accession
0001479290-22-000066
Insider Transaction Report
Form 4/AAmended
Kolaja Carey OConnor
Director
Transactions
- Award
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 totalExercise: $18.12Exp: 2032-05-03→ Common Stock (10,756 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary, May 4, 2023, subject to Ms. Kolaja's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual grant pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001848717
Filing Metadata
- Form type
- 4/A
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:10 PM ET
- Size
- 5.9 KB